Beta Thalassemia Testing Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Beta</strong> <strong>Thalassemia</strong> <strong>Testing</strong> <strong>Market</strong><br />
<strong>Beta</strong> thalassemia can be simplified as a diseased state of blood in which there is reduced hemoglobin<br />
production. Hemoglobin is a protein containing iron and is present in Red blood cells and the major<br />
function of hemoglobin is to carry oxygen to the body cells throughout the body. Low hemoglobin<br />
content in the beta thalassemia patients usually leads to the lack of oxygen in many parts of the body.<br />
Due to shortage of blood in the body patient, skin becomes pale yellow and the other symptoms like<br />
weakness and fatigue are prominent. Risk of abnormal blood clotting highly persist in the patients<br />
suffering from beta thalassemia.<br />
According to the symptoms severity the disease can be classified into three thalassemia major (Cooley's<br />
anemia), thalassemia intermediate and thalassemia minor. Amongst all the forms of thalassemia, major is<br />
considered to be the most dreadful. Diagnostics tests associated with <strong>Beta</strong> <strong>Thalassemia</strong> CBC Complete<br />
blood Count: CBC determines the amount of hemoglobin and RBC in the blood. Carriers possess regular<br />
hemoglobin level but may have a marginally reduced count of RBC. Patients having more severe type of<br />
thalassemia will have a lower RBC and hemoglobin levels. The detection of the diseased state comprises<br />
of measuring mean corpuscular volume which is the size of the RBC. Therefore the mean corpuscular<br />
volume is usually found declining in the patients of thalassemia. Hemoglobin tests will show a significant<br />
rise in A2 (>2.5%) and a fall in hemoglobin A (
Change language